Brian G. Kingwell Partner Patent Agent, Trademark Agent


Parle :  Anglais

Téléphone principal : +1 604-891-2258

Fax : +1 604-683-3558

Courriel : brian.kingwell@gowlingwlg.com

Télécharger vCard


Bureau principal :  Vancouver



Brian G. Kingwell

Brian Kingwell is a partner in the Vancouver office, practising in the firm's global Intellectual Property and Life Sciences groups.

For over 20 years, his practice has focused on patent prosecution and strategic patent portfolio counselling in the areas of molecular biology, genomics, biochemistry, chemistry, chemical engineering and medical devices. Brian advises innovative clients across a range of sectors and industries, including health care, biotechnology, agriculture and energy.

He has wide-ranging experience in obtaining patents for innovative products, examples of which include: a novel family of heterocyclic antibiotics, the InsectSelect™ protein expression vector, high oleic acid brassica juncea plants, in situ combustion processes for recovery of hydrocarbons, heavy metal waste remediation processes and Glybera®, the first human gene therapeutic approved in Europe. Brian is also the inventor of a patented medical device called the PeriPatch™ Sleeve, which was created on behalf of a client and has been marketed internationally.

The common thread across this range of experience is a creative and resourceful approach to maximizing the benefits of intellectual property for clients, helping clients to recognize risks and capitalize on opportunities.

Brian is a registered patent agent in both Canada and the United States.

Associations professionnelles

  • Canadian Bar Association
  • Fellow, Intellectual Property Institute of Canada; Chair of the Biotechnology Legislation Committee
  • Genome British Columbia's Genomics, Society, and Ethics Advisory Committee
  • Member and past President, Patent and Trade-mark Association of British Columbia
  • "Bottlenecks in translating genomics from the academy into the real world: risk, trust and communication" (co-authors: R. E. Ommer, J. Atkinson-Grosjean, C. Benoit, N. R. Caron, R. Downey, J. K. Hall, J. E. Halliwell and G. C. van Kooten), position paper prepared for Genome British Columbia, January 29th, 2012
  • Moderated IPIC's "Academic Research, Experimental Use and Patent Infringement" webinar, December 6, 2012
  • "A 'Bright Line' for the Patentability of Stem Cells?," co-authors: Jeffrey D. Morton and Michael D. Manson, Intellectual Property Magazine, 2010
  • "The role of patents in drug research," co-presenters: Andris D. Macins, Jeffrey D. Morton and J. Christopher Robinson, Centre for Drug Research and Development, Vancouver, March 2010
  • Adjunct professor, "Patent Law," University of Victoria, Victoria, BC 2001-2005
  • Adjunct professor, "Patent Law," University of British Columbia, Vancouver 2002
  • "Intellectual Property Protection for Transgenic Plants" (co-author: Joy D. Morrow) in "Transgenic Plants and Crops," edited by G. Khachatourians, Alan McHughen, Ralph Scorza, Wai-Kit Nip and Y. H. Hui, Marcel Dekker, 2002
  • "Recent Developments in Biotechnology Law" (co-author: J. Christopher Robinson), Lexpert, 2001
  • "Functional Language and Fingerprints," Canadian Intellectual Property Review(1993), vol. 10, No. 1, pp. 87
  • "Identification and characterization of a protein associated with the stembody using autoimmune sera from patients with systemic sclerosis" (co-authors: M.J. Fritzler, J. Decoteau and J.B. Rattner), Cell Motility and the Cytoskeleton(1987), 8(4), pp. 360-7
  • "Mammalian kinetochore/centromere composition: a 50 kDa antigen is present in the mammalian kinetochore/centromere" (co-author: J.B. Rattner), Chromosoma (1987), 95(6), pp. 403-7